Alpha Tau Medical (DRTS)
(Delayed Data from NSDQ)
$2.10 USD
+0.01 (0.52%)
Updated Jul 24, 2024 02:28 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Alpha Tau Medical Ltd. [DRTS]
Reports for Purchase
Showing records 1 - 13 ( 13 total )
Company: Alpha Tau Medical Ltd.
Industry: Unclassified
Company: Alpha Tau Medical Ltd.
Industry: Unclassified
Liver Cancer Metastases Trial Starts Patient Treatment; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Alpha Tau Medical Ltd.
Industry: Unclassified
Company: Alpha Tau Medical Ltd.
Industry: Unclassified
Pancreatic Cancer Trial Reports Promising Interim Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Alpha Tau Medical Ltd.
Industry: Unclassified
Pre-Market Approval Submission Accepted in Japan; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Alpha Tau Medical Ltd.
Industry: Unclassified
Company: Alpha Tau Medical Ltd.
Industry: Unclassified
First Pancreatic Cancer Patient Treated in Israel; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Alpha Tau Medical Ltd.
Industry: Unclassified
Company: Alpha Tau Medical Ltd.
Industry: Unclassified
Robust Long-Term Safety and Efficacy Data Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Alpha Tau Medical Ltd.
Industry: Unclassified
Company: Alpha Tau Medical Ltd.
Industry: Unclassified
First Patient Treated in SCC of Vulva Trial; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Alpha Tau Medical Ltd.
Industry: Unclassified
U.S. Pilot Feasibility Study Results Published; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Alpha Tau Medical Ltd.
Industry: Unclassified
Advancing Precision Alpha Particle Radiotherapy; Initiate at Buy and $9 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
|